Business Context and Reporting Period
Company: Becton, Dickinson and Company (BD)
Filing Type: Form 8-K (Current Report)
Date of Report: January 26, 2006
Reporting Period: First fiscal quarter of fiscal year 2006 (ended December 31, 2005). The filing primarily serves to announce financial results and provide forward-looking guidance for the fiscal year 2006.
Key Financial Metrics and Guidance
The filing does not contain specific GAAP revenue, profit, or cash flow figures for the reported quarter; these are referenced in the attached press release (Exhibit 99.1). However, the filing provides detailed estimated guidance for Diluted Earnings Per Share (EPS) from Continuing Operations for fiscal year 2006, including reconciliations for non-GAAP adjustments.
| Period (Estimated) | GAAP Diluted EPS Range | Adjusted EPS (Excl. GeneOhm & Insurance) |
|---|---|---|
| Three Months Ended March 31, 2006 | $0.78 - $0.79 | $0.76 - $0.77 |
| Six Months Ended March 31, 2006 | $1.63 - $1.64 | $1.59 - $1.60 |
| Six Months Ended Sept 30, 2006 | $1.57 - $1.60 | $1.57 - $1.60 |
| Twelve Months Ended Sept 30, 2006 | $3.20 - $3.24 | $3.15 - $3.19 |
Note: Adjustments exclude the impact of GeneOhm Sciences, Inc. operations and insurance settlements to reflect underlying performance.
Material Changes and Unusual Items
- GeneOhm Acquisition: BD anticipates the acquisition of GeneOhm Sciences, Inc. The guidance excludes the dilutive impact of this acquisition to improve comparability with prior periods. The filing notes that an in-process R&D charge may be recorded in connection with this acquisition, which is not reflected in the current estimates.
- Insurance Settlements: Management excludes the impact of concluded or anticipated insurance settlements from adjusted EPS and operating income measures to facilitate period-to-period comparisons.
- Tax Rate Adjustments: Adjusted tax measures exclude significant reversals of tax reserves, changes in tax laws, and the impact of the repatriation of foreign earnings under the American Jobs Creation Act.
Management Commentary and Risks
Management utilizes non-GAAP measures to evaluate underlying operational performance and for budget planning. They assert that these measures allow investors to view results without the impact of foreign exchange fluctuations, insurance settlements, and specific tax events. The filing explicitly states that non-GAAP results should not be considered in isolation or as a substitute for GAAP results, as excluded items may materially impact net income and cash flows.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for actual GAAP revenue, profit, and cash flow figures for Q1 2006, as they are not detailed in the 8-K text.
- Verify the magnitude of the potential in-process R&D charge related to the GeneOhm Sciences acquisition.
- Confirm the specific dollar impact of insurance settlements excluded from the adjusted EPS calculations.
- Assess the impact of foreign exchange rate fluctuations on reported revenue growth versus constant currency growth.